中信证券资产管理有限公司增持国药控股(01099)161万股每股作价约20.88港元

智通财经

2024-12-05

智通财经APP获悉，香港联交所最新资料显示，12月4日，中信证券资产管理有限公司增持国药控股(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。

本交易涉及其他关联方：中信证券-云帆单一资产管理计划。

补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2489043129"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489043129\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2489043129?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-12-05 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489043129","market":"hk","top_or_hot":-1,"title":"中信证券资产管理有限公司增持国药控股(01099)161万股 每股作价约20.88港元","media":"智通财经","content":"<html><body><p>智通财经APP获悉，香港联交所最新资料显示，12月4日，<a href=\"https://laohu8.com/S/600030\">中信证券</a>资产管理有限公司增持<a href=\"https://laohu8.com/S/01099\">国药控股</a>(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。</p><p>本交易涉及其他关联方：<a href=\"https://laohu8.com/S/06030\">中信证券</a>-云帆单一资产管理计划。</p><p>补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。</p><p><img src=\"https://img.zhitongcaijing.com/image/20241205/1733396583992836.png\" title=\"1733396583992836.png\"/></p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>中信证券资产管理有限公司增持国药控股(01099)161万股 每股作价约20.88港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中信证券资产管理有限公司增持国药控股(01099)161万股 每股作价约20.88港元\n</h2>\n<h4 class=\"meta\">\n\n\n2024-12-05 19:02 北京时间   <a href=\"http://www.zhitongcaijing.com/content/detail/1221000.html\"><strong>智通财经</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，香港联交所最新资料显示，12月4日，中信证券资产管理有限公司增持国药控股(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。本交易涉及其他关联方：中信证券-云帆单一资产管理计划。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - ...</p>\n<a href=\"http://www.zhitongcaijing.com/content/detail/1221000.html\">网页链接</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1997245094.SGD","symbol_name":"安联神州A股基金AT Acc SGD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1221000.html","article_id":"2489043129","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489043129","pubTimestamp":1733396574,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，香港联交所最新资料显示，12月4日，中信证券资产管理有限公司增持国药控股(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。本交易涉及其他关联方：中信证券-云帆单一资产管理计划。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600030":"中信证券","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1720050803.USD":"安联全方位中国股票基金","LU1997245177.USD":"安联神洲A股基金","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","BK1229":"房地产经营公司","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","BK1521":"挪威政府全球养老基金持仓","BK1542":"内地物业管理股","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","09983":"建业新生活","BK0196":"行业龙头","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","BK0012":"证金概念","BK0183":"MSCI概念","06030":"中信证券","BK1564":"中资券商股","01099":"国药控股","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","BK0276":"资本市场","BK1258":"房地产运营公司","BK1516":"腾讯概念","BK1515":"抗疫概念","BK0188":"融资融券","BK1147":"投资银行业与经纪业","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","BK1500":"做空集合股","BK1197":"保健护理产品经销商","BK0028":"国家队","BK1583":"高瓴概念"},"translate_title":"CITIC Securities Asset Management Co., Ltd. increased its holdings of 1.61 million shares of Sinopharm Holdings (01099) at a price of approximately HK $20.88 per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600030":1,"06030":1,"09983":1,"01099":1},"content_text":"智通财经APP获悉，香港联交所最新资料显示，12月4日，中信证券资产管理有限公司增持国药控股(01099)161万股，每股作价20.8751港元，总金额约为3360.89万港元。增持后最新持股数目为9414.44万股，最新持股比例为7.02%。本交易涉及其他关联方：中信证券-云帆单一资产管理计划。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0}}}